Sep 27, 2021 7:30am EDT iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update
Sep 20, 2021 7:30am EDT iBio to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update on Monday, September 27, 2021
Sep 07, 2021 4:30pm EDT iBio Announces Participation in H.C. Wainwright 23rd Annual Global Investment Conference
Aug 25, 2021 7:30am EDT iBio Expands Immuno-Oncology Pipeline in AI Partnership with RubrYc Therapeutics
Jul 15, 2021 5:10pm EDT iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate
Jul 08, 2021 4:15pm EDT iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs
Jun 09, 2021 4:30pm EDT iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink
